To evaluate the value of uterine artery Doppler in predicting adverse pregnancy outcomes among women with chronic hypertension in a tertiary hospital. Methods: This is a retrospective diagnostic validity study evaluating the value of uterine artery (UA) Doppler at 18-24 weeks age of gestation in predicting adverse pregnancy outcomes among women with Chronic Hypertension (CH) in a tertiary hospital from January 1, 2012 to December 31, 2013, who delivered 24 weeks or more. CH was defined as persistent BP greater than 140/90 mmHg diagnosed before pregnancy or before 20 gestation. Abnormal UA Doppler was described as the presence of an elevated uterine artery resistance index or the presence of a diastolic notch or both. Patients diagnosed with fetal congenital anomaly, other medical problems and higher order gestation were excluded. Results: Fifty-five % CH women had an abnormal UA Doppler and 45%of them had normal results. Among the CH patients with abnormal UA Doppler, the most common adverse pregnancy outcomes were superimposed pre-eclampsia (SPE) (57%), preterm delivery (43%), and IUGR (27%). The findings of abnormal UA Doppler has a high sensitivity of 92.6% and specificity of 63.3% for the development of SPE, with a PPV of 57% and a high negative predictive value of 94%. The positive likelihood ratio (LR) of CH women with abnormal UA Doppler to develop SPE is 2.5 higher compared to those with normal UA Doppler. Abnormal UA Doppler has a sensitivity of 38.1% and a specificity of 83.3% to have babies that are SGA with a positive LR of 2.29, PPV of 72.7% and negative predictive value of 53.6%. Abnormal UA Doppler has a low sensitivity of 5% and but a high specificity of 100% for stillbirth with a PPV 100% and negative predictive value of 46%. Conclusions: UA Doppler study between 18-24 weeks gestation among CH women could be a good predictor and screening tool to asses high risk women to develop adverse pregnancy outcomes especially superimposed pre-eclampsia.
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Objectives: Pre-eclampsia is multisystem disease occurred in 3-8% pregnancy, indicated by hypertension and proteinuria after 20 weeks of gestational age. In pre-eclamptic patients, pro-oxidant decrease enzymatically in cell, followed by increase in lipid peroxida due to free radicals malondialdehyde (MDA). Elevated free radicals in pre-eclampsia is associated with reduced cellular antioxidants. Curcumin has been known to posses many biology activities, such as anti-inflammation and antioxidants. Methods: We evaluated effects of curcumin on MDA level in pre-eclampsia induced HUVEC cell line. In the present study, we observe effects of curcumin on MDA level in pre-eclampsia induced HUVEC cell line. MDA level was measured with Thiobarbituric Acid-reactive Substances (TBARS).
Results:
The result of the present study showed curcumin decreased MDA level in pre-eclampsia-induced cell.
Conclusions: Curcumin has been studied recently in treatment of pre-eclampsia. Curcumin treatment in various doses could decrease significantly pro-inflammatory cytokines levels in pre-eclamptic plasma-induced. After curcumin treatment, there was decreased level of nuclear NF-kB p50 and increased level of PPAR-significantly. 24 In other study, LPS-curcumin-treated group had decreased blood pressure and urinary protein level, which was comparable to control group, as well as improved trophoblast invasion and spiral artery remodelling induced by LPS. Increased TLR4, NF-kB and IL-6, MCP-1 protein expressions in LPS-treated group were significantly decreased after curcumin administration.
EP16.06
Pravastatin improves placental perfusion and decreases umbilical artery vascular resistance in singleton pregnancies Objectives: Analysis of therapeutic effects of pravastatin on improvement of placental perfusion and decrease of umbilical artery vascular resistance in singleton pregnancies with increased umbilical artery pulsatility index for gestational age. Methods: In this study 10 pregnant patients, where isolated increased umbilical vascular resistance and normal uterine artery Doppler findings, were included. Pravastatin was administered to all patients between 19-28th week, when umbilical artery pulsatility index was measured above the limits for gestational age. Patients were scanned in 2-4 week interval to follow up changes in vascular resistance in umbilical artery. Results: Ten pregnant patients had singleton pregnancy. Gestational age, when increased umbilical vascular resistance was detected ranged from 19-28 weeks. Pravastatin was introduced when PI values in the umbilical artery were above normal limits for gestational age. Umbilical artery PI values decreased to normal range until term delivery in 9 patients. Fetal circulation and uterine arteries vascular resistance remained normal. All neonates were born without signs of intrauterine asphyxia. In one patient, who had normal umbilical artery vascular resistance until 28th week, Pravastatin was introduced after significant rise of umbilical artery PI to 1.5.Umbilical artery PI values remained unchanged until 35 weeks. Fetal cerebral circulation showed initial blood redistribution towards central nervous system. When cardiotocographic monitoring indicated initial asphyxia, Caesarean section was performed at 35 weeks of pregnancy. Histopathological examination of placenta confirmed placental infarction.
Conclusions:
In patients with isolated increased umbilical artery vascular resistance, with normal uterine artery vascular resistance, increased placental perfusion and decreased vascular resistance in umbilical arteries was achieved after administration of Pravastatin. Administration of Pravastatin reduced the incidence of early premature delivery due to fetal asphyxia.
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